Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Ayr Wellness Inc C.AYR.A

Alternate Symbol(s):  AYRWF

AYR Wellness Inc. is a vertically integrated multi-state cannabis operator in the United States. The Company operates simultaneously as a retailer with more than 90 licensed dispensaries and a house of cannabis consumer packed goods (CPG) brands. It is a cultivator, manufacturer and retailer of cannabis products and branded CPG, and is engaged in the manufacture, possession, use, sale, or... see more

CSE:AYR.A - Post Discussion

Ayr Wellness Inc > Echelon Capital 2021 Top Picks
View:
Post by retiredcf on Jan 14, 2021 8:12am

Echelon Capital 2021 Top Picks

As they are indicating on restriction, they may be revising upwards their current $53.00 target. GLTA

Equity analysts at Echelon Capital Markets unveiled their “Top Picks Portfolio” for the first quarter of 2020 in a research report released Thursday, calling it “an aggressive, catalyst-rich portfolio of high-growth, entrepreneurial companies.”

For the fourth quarter, the firm’s portfolio returned 40.1 per cent, beating both S&P/TSX Small Cap Index (23.5 per cent) and the broader S&P/TSX Composite Index (9.0 per cent). 

“The S&P/TSX Small Cap Index extended an outperformance streak over the broader TSX Composite to three consecutive quarters,” the firm said. “This reflects an aggressive recovery from the 38.1-per-cent Q120 decline when it underperformed the 20.9-per-cent decline for the broader Composite Index. We look for investors to remain focused on the high-quality small cap names with specific catalysts or underlying secular growth trends in an environment where low interest rates are expected to persist.” 

“Our Top Picks Portfolio 2020 full year return at 74.0 per cent outperformed the 2020 total return of the S&P/TSX Composite and the Small Cap Index by 68.4 per cent and 61.1 per cent, respectively. The Top Picks Portfolio outperformed the Small Cap Index (our closest benchmark) in all four quarters this year and posted three consecutive quarters of double-digit outperformance over the S&P/TSX Composite Index.”

The firm said 8 of the 13 equities selected for the quarter are returning names, which it said is “signalling confidence in our Top Picks continuing to benefit from underlying secular growth trends and ample catalyst opportunities.”

The returning equities are:

AYR Strategies Inc. (AYR.A-CN, on restriction)

Mr. Semple: “Ayr’s Q420 return of 81 per cent was better than both the New Cannabis Ventures Global Cannabis Stock Index return of 62 per cent and our tracking group of U.S. cannabis MSOs of 71 per cent. Ayr outperformed as it executed on all the catalysts we had hoped for. It closed on the first of its pending acquisitions, announced new M&A, completed a non-dilutive financing, and reported solid Q320 results with 61-per-cent quarter-over-quarter sales growth. We believe Ayr’s stock has ample room to rise further.

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities